Encodia

San Diego, United States Founded: 2015 • Age: 11 yrs
Technology platforms for integrative proteomic analysis are developed.

About Encodia

Encodia is a Healthcare company based in San Diego (United States) founded in 2015. Technology platforms for integrative proteomic analysis are developed. Encodia has raised $75 million across 4 funding rounds from investors including ARE, Arch Venture Partners and Deerfield. The company has 85 employees. Encodia offers products and services including ProteoCode. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Proteomics. Its legal entity is ENCODIA, INC. Its competitors include Tierra Biosciences, Amide Technologies and Aquagene; 2 of its 3 listed competitors have raised funding.

Company details

Encodia was founded in 2015 and is based in San Diego, United States. Integrative proteomic analysis is supported through developed technology platforms. Fluidics-based instruments are offered to facilitate automatic multi-step biochemical and chemical processes. Operations focus on the biotechnology sector, with services centered on proteomic tools for research applications. The companys domain is encodia.com.

  • Headquarters San Diego, United States
  • Employees 85
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website encodia.com
  • Social LinkedIn X
  • Legal Name Encodia, Inc.
Key Metrics
  • Total Equity Funding
    $75M (USD)

    in 4 rounds

  • Latest Funding Round
    $75M (USD), Series C

    Jan 2021

  • Investors
    ARE

    & 9 more

  • Employee Count
    85

Products & Services of Encodia

Encodia offers a comprehensive portfolio of products and services, including ProteoCode.

ProteoCode
Protein Sequencing Technology

Enables scalable NGS-based analysis of protein libraries for health innovations.

Funding Insights of Encodia

Encodia has successfully raised a total of $75M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $75M
  • Total Rounds 4
  • Last Round Series C β€” $75M
  • First Round $222,959

    (Jun 2018)

  • Investors Count 10

All 4 funding rounds of Encodia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2021$75MSeries C–Deerfield, Northpond Ventures
Nov 2018Seed–Biomatics Capital
–
Jun 2018$222,959Grant––
Jun 2018$718,340Grant––
Valuation history

10 investors in total: 10 institutional.

Investors in Encodia

Encodia has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Arch Venture Partners and Deerfield.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Healthcare ecosystem is supported through investment and innovation by Deerfield.
deerfield.comNew York, United States
Corporate backed venture capital fund investing in multiple sectors
gv.comMountain View, United States
Venture capital firm focused on life science companies
1986archventure.comChicago, United States
Venture capital firm focused on life science and technology sectors
decheng.comShanghai, China
Venture capital firm focused on multiple sectors
taocap.comMarlborough, United States
Early-stage tech and life sciences focused VC firm investing primarily in the US
biomaticscapital.comSeattle, United States
Corporate backed venture capital firm investing in life sciences sector
nanfunglifesciences.comSan Francisco, United States
Venture capital firm investing in life sciences & tech sectors
npv.vcCambridge, United States
sbir.nih.gov
REIT that invests in campuses, multi-tenant spaces and build-to-suit facilities in the US
1994are.comPasadena, United States
Premium access

Investor details for Encodia

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Encodia

11 people are tracked at Encodia (4 in leadership, 5 in board & advisors, 2 in team); the tracked headcount is 85.

NameRoleGroup
Mark Chee
Co-Founder & PresidentLeadership
Nigel Beard
CTOLeadership
Li Yu
VP Of FinanceLeadership
Silvia Gravina
Director, Product Applications & StrategyLeadership
David Cruikshank
PartnerBoard & advisors
Michael Weiner
PartnerBoard & advisors
Andrew Elbardissi
Board MemberBoard & advisors
Adam Wieschhaus
PartnerBoard & advisors
Sharon Kedar
PartnerBoard & advisors
Daniel Chang
Senior Information Technology ManagerTeam
Travis Lippert
Staff Program ManagerTeam
Premium access

Complete people profiles for Encodia

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Encodia

3 dated milestones of Encodia across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Encodia is founded.
  2. Funding First funding round of $223K.
  3. Funding Latest funding round, Series C, of $75.0M.

Competitors of Encodia

Encodia has 3 listed competitors in our database, 2 of them funded. They include Tierra Biosciences, Amide Technologies and Aquagene.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tierrabiosciences.com2015Berkeley, United States$31.56M11
AI-based tools for protein development and custom synthesis are offered.
amidetech.com2017Cambridge, United States$16.5M8
Automated peptide synthesis platform is developed with precision reagents.
aquagene.com1996Alachua, United States
Produces high-quality recombinant proteins for research and industrial applications.
Premium access

Detailed competitors of Encodia

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Encodia

The website of Encodia (encodia.com) receives about 1.9K visits a month.

  • Monthly visits
    1.9K

    ▲ 74.5% vs previous month

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Encodia (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Encodia

Premium access

Complete news archive for Encodia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Encodia

Encodia was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Encodia is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Encodia is a funded company, having raised a total of $75M across 4 funding rounds to date. The company's 1st funding round was a Grant of $222.96K, raised on Jun 2018.

Encodia has 85 employees.

Encodia was founded in 2015 and is based in San Diego, United States. Integrative proteomic analysis is supported through developed technology platforms. Fluidics-based instruments are offered to facilitate automatic multi-step biochemical and chemical processes. Operations focus on the biotechnology sector, with services centered on proteomic tools for research applications. The companys domain is encodia.com.

Encodia's top competitors include Tierra Biosciences, Amide Technologies and Aquagene.

Encodia offers ProteoCode.

Encodia has 10 investors. Key investors include ARE, Arch Venture Partners, Deerfield, Google Ventures, and Decheng Capital.

Encodia operates through Encodia, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available